DCGI Cracks Down on Unauthorised GLP-1 Weight-Loss Drugs
Published on: March 24, 2026, 10:46 a.m. | Source: Devdiscourse
The Drugs Controller General of India (DCGI) is intensifying regulatory measures to prevent the unauthorised sale and promotion of GLP-1 class weight-loss drugs. Numerous inspections and audits have targeted online pharmacy warehouses and retailers to curb malpractice and ensure patient safety, with stricter regulations on the horizon.
